Morphologic Features of Carcinoid Heart Disease as Assessed by Three-Dimensional Transesophageal Echocardiography

被引:4
作者
Nalawadi, Smruti S. [1 ,2 ]
Siegel, Robert J. [1 ,2 ]
Wolin, Edward [3 ]
Yu, Run [3 ]
Trento, Alfredo [1 ,2 ]
Shiota, Takahiro [1 ,2 ]
Tolstrup, Kirsten [1 ,2 ]
Luthringer, Daniel [4 ]
Gurudevan, Swaminatha [1 ,2 ]
机构
[1] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Div Cardiovasc Surg, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA
来源
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2010年 / 27卷 / 09期
关键词
three-dimensional transesophageal echocardiography; transesophageal echocardiography; tricuspid regurgitation; FUNCTIONAL TRICUSPID REGURGITATION; TUMORS; ABNORMALITIES; PROGRESSION; SEROTONIN; PROGNOSIS;
D O I
10.1111/j.1540-8175.2010.01207.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Carcinoid heart disease (CHD) is a rare cause of valvular heart disease and carries a poor prognosis. CHD has a unique morphology and echocardiographic features that predominantly involve right-sided valvular structures. The diagnosis of CHD is usually made by two-dimensional transthoracic echocardiography (TIE). With the superior spatial resolution of real time three-dimensional transesophageal echocardiography (3DTEE), structural changes that occur in patients with CHD-associated valvular heart disease can be examined in greater detail. We undertook this study to examine the incremental value of 3DTEE in the diagnosis of CHD. Methods: A total of four patients with CHD underwent TIE, transesophageal echocardiography (TEE), and 3DTEE as part of their routine clinical evaluation. Results: TIE and TEE for all four patients revealed thickened, fibrosed, retracted, and malcoapted tricuspid leaflets with wide-open tricuspid valve regurgitation. 3DTEE en face imaging of the tricuspid valve demonstrated the characteristic morphologic features of CHD more clearly in all four patients. Conclusions: 3DTEE provides substantial incremental value over TIE in the assessment of characteristic CHD pathology and thus enhances the echocardiographic diagnosis of CHD. (Echocardiography 2010;27:1098-1105)
引用
收藏
页码:1098 / 1105
页数:8
相关论文
共 25 条
[1]   Carcinoid heart disease [J].
Bhattacharyya, Sanjeev ;
Davar, Joseph ;
Dreyfus, Gilles ;
Caplin, Martyn E. .
CIRCULATION, 2007, 116 (24) :2860-2865
[2]   Carcinoid heart disease associated with primary ovarian carcinoid tumor [J].
Chaowalit, N ;
Connolly, HM ;
Schaff, HV ;
Webb, MJ ;
Pellikka, PA .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (10) :1314-1315
[3]  
Connolly HM, 2001, CIRCULATION, V104, pI36
[4]   Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease [J].
Denney, WD ;
Kemp, WE ;
Anthony, LB ;
Oates, JA ;
Byrd, BF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (04) :1017-1022
[5]  
FELDMAN JM, 1986, CLIN CHEM, V32, P840
[6]   Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation - A real-time, 3-dimensional echocardiographic study [J].
Fukuda, Shota ;
Saracino, Giuseppe ;
Matsumura, Yoshiki ;
Daimon, Masao ;
Tran, Hung ;
Greenberg, Neil L. ;
Hozumi, Takeshi ;
Yoshikawa, Junichi ;
Thomas, James D. ;
Shiota, Takahiro .
CIRCULATION, 2006, 114 :I492-I498
[7]   CLINICAL AND ECHOCARDIOGRAPHIC COMPARISON OF PATIENTS WITH THE CARCINOID-SYNDROME WITH AND WITHOUT CARCINOID HEART-DISEASE [J].
HIMELMAN, RB ;
SCHILLER, NB .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (05) :347-352
[8]   Carcinoid tumors [J].
Kulke, MH ;
Mayer, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (11) :858-868
[9]   TREATMENT OF THE MALIGNANT CARCINOID-SYNDROME - EVALUATION OF A LONG-ACTING SOMATOSTATIN ANALOG [J].
KVOLS, LK ;
MOERTEL, CG ;
OCONNELL, MJ ;
SCHUTT, AJ ;
RUBIN, J ;
HAHN, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (11) :663-666
[10]   CARCINOID HEART-DISEASE - RELATIONSHIP OF CIRCULATING VASOACTIVE SUBSTANCES TO ULTRASOUND-DETECTABLE CARDIAC ABNORMALITIES [J].
LUNDIN, L ;
NORHEIM, I ;
LANDELIUS, J ;
OBERG, K ;
THEODORSSONNORHEIM, E .
CIRCULATION, 1988, 77 (02) :264-269